{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:46:59Z","timestamp":1792802819559,"version":"4.5.0"},"reference-count":201,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148811","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T23:13:17Z","timestamp":1762729997000},"page":"148811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"P2","title":["Nutraceuticals in breast cancer therapy: Mechanistic insights and therapeutic potential"],"prefix":"10.1016","volume":"333","author":[{"given":"Srinivas","family":"Ganjipete","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavana Gowda Hosur","family":"Dinesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Bandral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohankumar","family":"Ramar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damodar Nayak","family":"Ammunje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parasuraman","family":"Pavadai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.148811_bb0005","first-page":"133","article-title":"Incidence and Etiology","author":"Krishnamurthy","year":"2023","journal-title":"Fundamentals in Gynaecologic Malignancy."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0010","series-title":"Introduction to Breast Cancer. Therapeutic Potential of Cell Cycle Kinases in Breast Cancer","first-page":"1","author":"Mir","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0015","series-title":"The Molecular Basis of Human Cancer","first-page":"401","article-title":"Hereditary breast and ovarian cancer","author":"Lux","year":"2016"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000507554","article-title":"The metabolic syndrome is a risk factor for breast cancer: a systematic review and meta-analysis","volume":"13","author":"Zhao","year":"2020","journal-title":"Obes. Facts"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148811_bb0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/jnci\/djab023","article-title":"Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis","volume":"113","author":"Lohmann","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0030","series-title":"Breast Cancer: Targets and Therapy","first-page":"525","article-title":"Diagnostic and prognostic biomarkers of luminal breast cancer: where are we now?","author":"H\u00f6ller","year":"2023"},{"issue":"31","key":"10.1016\/j.ijbiomac.2025.148811_bb0035","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2174\/0113816128357976250122042633","article-title":"Targeting the PI3K pathway: advancements and achievements in breast cancer therapy","volume":"31","author":"Dinesh","year":"2025","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/jbi\/wbaa110","article-title":"Molecular subtypes of breast cancer: a review for breast radiologists","volume":"3","author":"Johnson","year":"2021","journal-title":"Journal of Breast Imaging."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143948","article-title":"ATAD2 bromodomain in cancer therapy: current status and future perspectives","volume":"311","author":"Biju","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0050","series-title":"Biologics: Targets and Therapy","first-page":"289","article-title":"The molecular profile of luminal B breast cancer","author":"Creighton","year":"2012"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0055","series-title":"Classification of Breast Cancer Through the Perspective of Cell Identity Models. A Guide to Breast Cancer Research: From Cellular Heterogeneity and Molecular Mechanisms to Therapy","first-page":"185","author":"Iggo","year":"2025"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0060","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","article-title":"HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab","volume":"73","author":"Ithimakin","year":"2013","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0065","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1158\/1078-0432.CCR-08-2132","article-title":"Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes","volume":"15","author":"Rakha","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djn419","article-title":"Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells","volume":"101","author":"Sieuwerts","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0075","first-page":"83","article-title":"HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+\/HER2+ breast cancer","author":"Bergamino","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0080","series-title":"Triple-Negative\/Basal-Like Breast Carcinomas. A Comprehensive Guide to Core Needle Biopsies of the Breast","first-page":"431","author":"Calhoun","year":"2016"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0085","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10330-010-0024-8","article-title":"Research progress in triple-negative breast cancer","volume":"9","author":"Lu","year":"2010","journal-title":"Chin.-Ger. J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.152874","article-title":"Progress in triple negative breast carcinoma pathophysiology: potential therapeutic targets","volume":"216","author":"Yu","year":"2020","journal-title":"Pathology-Research and Practice."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0095","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0100","series-title":"Breast Cancer: Targets and Therapy","first-page":"15","article-title":"Treatment strategies against triple-negative breast cancer: an updated review","author":"Maqbool","year":"2023"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1568009620666200506110850","article-title":"Targeted drug therapy to overcome chemoresistance in triple-negative breast cancer","volume":"20","author":"Kumari","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40246-022-00447-3","article-title":"Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1\/2 mutations","volume":"17","author":"Kim","year":"2023","journal-title":"Hum. Genomics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0115","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-018-4753-7","article-title":"Mutant p53 in breast cancer: potential as a therapeutic target and biomarker","volume":"170","author":"Duffy","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","article-title":"PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer","volume":"22","author":"Glaviano","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0125","first-page":"1","article-title":"Dual targeting of the PI3K and MAPK pathways in breast cancer","volume":"2","author":"Saini","year":"2010","journal-title":"Asia Pacific Journal of Oncology & Hematology."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1042\/BST20220866","article-title":"The mechanisms of class 1A PI3K and Wnt\/\u03b2-catenin coupled signaling in breast cancer","volume":"51","author":"Rodgers","year":"2023","journal-title":"Biochem. Soc. Trans."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0135","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1186\/s12964-024-01812-6","article-title":"Interactions between hedgehog signaling pathway and the complex tumor microenvironment in breast cancer: current knowledge and therapeutic promises","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun. Signal"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0140","article-title":"Estrogen receptor: current understanding of its activation and modulation","volume":"7","author":"Osborne","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0145","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.3390\/cancers3021691","article-title":"Epigenetics of estrogen receptor signaling: role in hormonal cancer progression and therapy","volume":"3","author":"Mann","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1495221","article-title":"The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications","volume":"15","author":"Duan","year":"2024","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148811_bb0155","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3390\/ijms22115421","article-title":"Inflammation-induced tumorigenesis and metastasis","volume":"22","author":"Hibino","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0160","series-title":"Angiogenesis and Immune Suppression in Cancer. Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal","first-page":"213","author":"Motz","year":"2014"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.29074\/ascls.28.1.38","article-title":"The suppression and promotion of cancer: the dichotomy of tumor immunology","volume":"28","author":"Landis-Piwowar","year":"2015","journal-title":"American Society for Clinical Laboratory Science."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.52711\/2321-5836.2024.00034","article-title":"Breast cancer: from etiology to therapeutic interventions","volume":"16","author":"Singh","year":"2024","journal-title":"Research Journal of Pharmacology and Pharmacodynamics."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0175","first-page":"735","article-title":"Treatment strategies and survival outcomes in breast cancer","author":"Cheung","year":"2020","journal-title":"MDPI"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0180","series-title":"Real world outcomes of 2,339 patients with early-stage triple-negative breast cancer (TNBC) treated in British Columbia","author":"Lucas","year":"2024"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0185","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ijrobp.2010.04.053","article-title":"Breast cancer: A multidisciplinary approach to diagnosis and management","volume":"78","author":"Leonard","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2025.148811_bb0190","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.4103\/ijc.IJC_1394_20","article-title":"BRCA mutations: implications of genetic testing in ovarian cancer","volume":"59","author":"Talwar","year":"2022","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0195","series-title":"Neoadjuvant Treatment in Breast Cancer. Oncoplastic and Reconstructive Breast Surgery","first-page":"173","author":"Wang","year":"2019"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/OP.23.00830","article-title":"Current and novel treatment options in hormone receptor\u2013positive, human epidermal growth factor receptor 2\u2013negative metastatic breast cancer","volume":"21","author":"Lopetegui-Lia","year":"2025","journal-title":"JCO Oncology Practice."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0205","first-page":"222","article-title":"\u041f\u043e\u0441\u0442\u043d\u0435\u043e\u0430\u0434\u044a\u044e\u0432\u0430\u043d\u0442\u043d\u043e\u0435 \u043b\u0435\u0447\u0435\u043d\u0438\u0435 \u0440\u0430\u043a\u0430 \u043c\u043e\u043b\u043e\u0447\u043d\u043e\u0439 \u0436\u0435\u043b\u0435\u0437\u044b","volume":"9","author":"\u0421\u0435\u043c\u0438\u0433\u043b\u0430\u0437\u043e\u0432","year":"2020","journal-title":"\u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0441\u043e\u0432\u0435\u0442."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0210","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2049-3002-2-8","article-title":"Mitochondria and cancer","volume":"2","author":"Chandel","year":"2014","journal-title":"Cancer & Metabolism"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0215","unstructured":"Zohaib M, Mubarik MZ, Sattar A, Zafar A, Naseem A, Yasmeen F, et al. Metabolic Alterations in Cancer Cells Exploring the Relationship Between Biochemical and Molecular Events that Drive Tumorigenesis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0220","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7150\/ijbs.81609","article-title":"An overview: the diversified role of mitochondria in cancer metabolism","volume":"19","author":"Ye","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0225","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s10020-024-00899-4","article-title":"Mitochondria: a new intervention target for tumor invasion and metastasis","volume":"30","author":"Zhou","year":"2024","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0230","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s43042-024-00485-7","article-title":"Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context","volume":"25","author":"Saddam","year":"2024","journal-title":"Egyptian Journal of Medical Human Genetics."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0235","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1042\/BCJ20210854","article-title":"The concept of intrinsic versus extrinsic apoptosis","volume":"479","author":"Lossi","year":"2022","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF02913307","article-title":"Apoptosis in health and disease and modulation of apoptosis for therapy: an overview","volume":"22","author":"Singh","year":"2007","journal-title":"Indian J. Clin. Biochem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004252","article-title":"Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens","volume":"10","author":"Caulfield","year":"2014","journal-title":"PLoS Pathog."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.148811_bb0250","doi-asserted-by":"crossref","first-page":"14871","DOI":"10.1073\/pnas.96.26.14871","article-title":"Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL","volume":"96","author":"Huang","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985363","article-title":"The role of BCL-2 family proteins in regulating apoptosis and cancer therapy","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0260","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1582-4934.2003.tb00225.x","article-title":"Regulation of apoptosis by Bcl-2 family proteins","volume":"7","author":"Burlacu","year":"2003","journal-title":"J. Cell. Mol. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0265","article-title":"The driving power of the cell cycle: cyclin-dependent kinases, cyclins and their inhibitors","volume":"124","author":"Hives","year":"2023","journal-title":"Bratislava Medical Journal\/Bratislavsk\u00e9 Lek\u00e1rske Listy."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148811_bb0270","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400769R","article-title":"Cell cycle machinery in oncology: a comprehensive review of therapeutic targets","volume":"38","author":"Cavalu","year":"2024","journal-title":"FASEB J."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0275","series-title":"MLL-SEPTIN Gene Fusions in Hematological Malignancies","author":"Cerveira","year":"2011"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0280","first-page":"109","article-title":"Cyclin dependent kinases: old target with new challenges for anti-cancer drugs","volume":"12","author":"Choudhary","year":"2022","journal-title":"Int J Cancer Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb0285","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/molecules24061131","article-title":"RETRACTED: resveratrol inhibits the migration and metastasis of MDA-MB-231 human breast cancer by Reversing TGF-\u03b21-induced epithelial-mesenchymal transition","volume":"24","author":"Sun","year":"2019","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb0290","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mnfr.200700325","article-title":"Resveratrol inhibits migration and invasion of human breast-cancer cells","volume":"52","author":"Tang","year":"2008","journal-title":"Mol. Nutr. Food Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0295","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1139\/bcb-2014-0067","article-title":"Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9","volume":"93","author":"Li","year":"2015","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0300","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.2147\/OTT.S140886","article-title":"Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of RhoA and Rac1","author":"Li","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0305","series-title":"Cancer and Angiogenesis. Oncodynamics: Effects of Cancer Cells on the Body","first-page":"39","author":"Miller","year":"2016"},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.148811_bb0310","first-page":"917","article-title":"Vascular endothelial growth factor (VEGF) in cancer","volume":"8","author":"Manzoor","year":"2014","journal-title":"Afr. J. Pharm. Pharmacol"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0315","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.critrevonc.2007.01.006","article-title":"Vascular endothelial growth factor (VEGF) signaling in tumor progression","volume":"62","author":"Roskoski","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0320","series-title":"Angiogenesis: A Therapeutic Target for Cancer. Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models","first-page":"165","author":"Atale","year":"2020"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148811_bb0325","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.2174\/0109298673325229240928040758","article-title":"Anticancer drug discovery from natural compounds targeting PI3K\/AKT\/mTOR signaling pathway","volume":"32","author":"Figueiredo da Silva","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0330","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3390\/molecules29071570","article-title":"Flavonoids with anti-angiogenesis function in cancer","volume":"29","author":"Wei","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0335","series-title":"Breast Cancer: Targets and Therapy","first-page":"9","article-title":"Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells","author":"Cook","year":"2016"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.148811_bb0340","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1111\/febs.16125","article-title":"Autophagy and tumorigenesis","volume":"289","author":"Rangel","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217285","article-title":"Autophagy and cancer therapy","volume":"605","author":"Pimentel","year":"2024","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148811_bb0350","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.3390\/cancers11101422","article-title":"The emerging roles of mTORC1 in macromanaging autophagy","volume":"11","author":"Dossou","year":"2019","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0355","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.3390\/molecules27072165","article-title":"Natural small molecules in breast cancer treatment: understandings from a therapeutic viewpoint","volume":"27","author":"Islam","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1172245","article-title":"Editorial: Targeting triple negative breast cancer by natural compounds","volume":"14","author":"Kumar","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0365","doi-asserted-by":"crossref","DOI":"10.52783\/jns.v14.2210","article-title":"Medicinal plants and traditional uses and modern applications","volume":"14","author":"Manisha","year":"2025","journal-title":"Journal of Neonatal Surgery"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.59566\/IJBS.2009.5001","article-title":"Overview of major classes of plant-derived anticancer drugs","volume":"5","author":"Amin","year":"2009","journal-title":"Int. J. Biomed. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0375","doi-asserted-by":"crossref","first-page":"274","DOI":"10.53771\/ijstra.2023.4.1.0027","article-title":"Vinca (Catharanthus roseus) containing phytochemicals and pharmacological profile","volume":"4","author":"Jadhav","year":"2023","journal-title":"Int J Sci Technol Res Arch."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0380","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.sajb.2023.08.034","article-title":"Biosynthesis, extraction, detection and pharmacological attributes of vinblastine and vincristine, two important chemotherapeutic alkaloids of Catharanthus roseus (L.) G. Don: A review","volume":"161","author":"Paul","year":"2023","journal-title":"S. Afr. J. Bot."},{"issue":"36","key":"10.1016\/j.ijbiomac.2025.148811_bb0385","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.2174\/0929867324666171006144208","article-title":"Polyphenols in food: cancer prevention and apoptosis induction","volume":"25","author":"Sharma","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0390","doi-asserted-by":"crossref","first-page":"7619","DOI":"10.21037\/tcr-20-2359","article-title":"Functions of polyphenols and its anticancer properties in biomedical research: a narrative review","volume":"9","author":"Bhosale","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0395","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3390\/ijms24021680","article-title":"The involvement of natural polyphenols in molecular mechanisms inducing apoptosis in tumor cells: a promising adjuvant in cancer therapy","volume":"24","author":"Chimento","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0400","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12935-023-03081-8","article-title":"Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs","volume":"23","author":"Wang","year":"2023","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0405","article-title":"Hepatocellular carcinoma and miRNAs: an in silico approach revealing potential therapeutic targets for polyphenols","volume":"2","author":"de Almeida Chuffa","year":"2022","journal-title":"Phytomedicine Plus."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0410","doi-asserted-by":"crossref","DOI":"10.1080\/09540105.2023.2280524","article-title":"Curcumin: a bioactive compound with molecular targets for human malignancies","volume":"34","author":"Shahbaz","year":"2023","journal-title":"Food Agric. Immunol."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148811_bb0415","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.3390\/cancers13143427","article-title":"Curcumin: modulator of key molecular signaling pathways in hormone-independent breast cancer","volume":"13","author":"Farghadani","year":"2021","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148811_bb0420","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/nu11102376","article-title":"Curcumin and cancer","volume":"11","author":"Giordano","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148811_bb0425","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1002\/ptr.7121","article-title":"Curcumin and cancer biology: focusing regulatory effects in different signalling pathways","volume":"35","author":"Bhatia","year":"2021","journal-title":"Phytother. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2174\/1570161116666180209113014","article-title":"Anti-angiogenic activity of curcumin in cancer therapy: a narrative review","volume":"17","author":"Shakeri","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0435","series-title":"AIP Conference Proceedings","doi-asserted-by":"crossref","DOI":"10.1063\/5.0016423","article-title":"Effect of curcumin on NF-\u03baB P105\/50 expression on triple-negative breast cancer (TNBC) and its possible mechanism of action","author":"Murwanti","year":"2020"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0440","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1479-5876-9-71","article-title":"Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells","volume":"9","author":"Rao","year":"2011","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0445","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12964-023-01207-z","article-title":"NF-\u03baB signaling in neoplastic transition from epithelial to mesenchymal phenotype","volume":"21","author":"Oh","year":"2023","journal-title":"Cell Commun. Signal"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0450","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3390\/cancers16081554","article-title":"The role of curcumin in cancer: a focus on the PI3K\/Akt pathway","volume":"16","author":"Zoi","year":"2024","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0455","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10565-019-09471-x","article-title":"Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1\/2 signaling","volume":"35","author":"Hu","year":"2019","journal-title":"Cell Biol. Toxicol."},{"issue":"33","key":"10.1016\/j.ijbiomac.2025.148811_bb0460","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1080\/10408398.2022.2101428","article-title":"Effects and mechanisms of resveratrol for prevention and management of cancers: an updated review","volume":"63","author":"Wu","year":"2023","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0465","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijc.11720","article-title":"Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor \u03b1-dependent mechanism: Relevance in cell proliferation","volume":"109","author":"Pozo-Guisado","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0470","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12935-021-02179-1","article-title":"STAT3 pathway as a molecular target for resveratrol in breast cancer treatment","volume":"21","author":"Kohandel","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148811_bb0475","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1007\/s10495-017-1394-y","article-title":"Novel combination of salinomycin and resveratrol synergistically enhances the anti-proliferative and pro-apoptotic effects on human breast cancer cells","volume":"22","author":"Dewangan","year":"2017","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0480","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1039\/C9TB02051A","article-title":"Anti-breast cancer activity of resveratrol encapsulated in liposomes","volume":"8","author":"Zhao","year":"2020","journal-title":"J. Mater. Chem. B"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0485","article-title":"Green tea\u2019s EGCG: brewing hope in the battle against breast cancer","volume":"16","author":"Kumar","year":"2025","journal-title":"Nat. Prod. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0490","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/21655979.2019.1657327","article-title":"Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25","volume":"10","author":"Zan","year":"2019","journal-title":"Bioengineered"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0495","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3892\/ol.2017.6641","article-title":"Mechanism of EGCG promoting apoptosis of MCF-7 cell line in human breast cancer","volume":"14","author":"Huang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0500","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/1535-7163.81.4.1","article-title":"Epigallocatechin-3-gallate induces apoptosis in estrogen receptor\u2013negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation","volume":"4","author":"Roy","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0505","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1940-6207.CAPR-11-0009","article-title":"A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells","volume":"4","author":"Meeran","year":"2011","journal-title":"Cancer Prev. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0510","first-page":"1403","article-title":"(-)-Epigallocatechin-3-gallate induces apoptosis in gastric cancer cell lines by down-regulating survivin expression","volume":"38","author":"Onoda","year":"2011","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0515","series-title":"Therapeutic Applications in Disease and Injury","first-page":"249","article-title":"Breast cancer stem cell: translating to the clinic. stem cells and cancer stem cells","volume":"Vol. 4","author":"Ono","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0520","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1221175","article-title":"Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications","volume":"11","author":"Ordaz-Ramos","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0525","first-page":"39","article-title":"Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3\u2013NF\u03baB signaling","volume":"35","author":"Chung","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0530","article-title":"Effect of EGCG on invasion of breast cancer cells and its possible mechanism","volume":"12","author":"Deng","year":"2000","journal-title":"Chin. J. Pathophysiol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0535","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4161\/cbt.6.12.4974","article-title":"Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells","volume":"6","author":"Thangapazham","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0540","series-title":"Molecular Mechanisms of Flavonoids Mediated Therapy and Chemoprevention of Cancer. Functional Foods for Health Maintenance: Understanding their Role in Cancer Prevention","first-page":"199","author":"Kaur","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0545","series-title":"Role of Flavonoids in Chronic Metabolic Diseases: From Bench to Clinic","first-page":"67","article-title":"Dietary sources, classification, biosynthesis, and mechanism of action of flavonoids in combating oxidative stress","author":"Khan","year":"2024"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148811_bb0550","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/foods13142253","article-title":"Anticancer potential of flavonoids: their role in cancer prevention and health benefits","volume":"13","author":"Pyo","year":"2024","journal-title":"Foods"},{"issue":"20","key":"10.1016\/j.ijbiomac.2025.148811_bb0555","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1128\/MCB.23.20.7256-7270.2003","article-title":"c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL","volume":"23","author":"Maclean","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"238","key":"10.1016\/j.ijbiomac.2025.148811_bb0560","first-page":"2","article-title":"Basic studies on chemopreventive properties of quercetin and curcumin and other plant-origin compounds in ovarian cancer cells\u2013a mini-review","volume":"6","author":"Kujawski","year":"2017","journal-title":"Altern Integr Med."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb0565","first-page":"1453","article-title":"Quercetin inhibits human breast cancer cell proliferation and induces apoptosis via Bcl-2 and Bax regulation","volume":"5","author":"Duo","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1021624520740","article-title":"Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-\u03baB pathway in lipopolysaccharide-stimulated macrophage","volume":"243","author":"Cho","year":"2003","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148811_bb0575","doi-asserted-by":"crossref","DOI":"10.1111\/1750-3841.12223","article-title":"Quercetin suppresses intracellular ROS formation, MMP activation, and cell motility in human fibrosarcoma cells","volume":"78","author":"Lee","year":"2013","journal-title":"J. Food Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0580","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10787-019-00660-y","article-title":"Therapeutic potential of quercetin on human breast cancer in different dimensions","volume":"28","author":"Kasiri","year":"2020","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0585","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.743837","article-title":"Baicalein potentiated M1 macrophage polarization in cancer through targeting PI3K\u03b3\/NF-\u03baB signaling","volume":"12","author":"He","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107032","article-title":"Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: a comprehensive review with future perspectives","volume":"199","author":"Wang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0595","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0007114507811974","article-title":"The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression","volume":"99","author":"Wang","year":"2008","journal-title":"Br. J. Nutr."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0600","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/01635580701268196","article-title":"Effects of flavonoids genistein and biochanin A on gene expression and their metabolism in human mammary cells","volume":"57","author":"Moon","year":"2007","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tifs.2018.07.001","article-title":"Biochanin A: a phytoestrogen with therapeutic potential","volume":"79","author":"Raheja","year":"2018","journal-title":"Trends Food Sci. Technol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0610","first-page":"5989","article-title":"Biochanin A induces anticancer effects in SK-Mel-28 human malignant melanoma cells via induction of apoptosis, inhibition of cell invasion and modulation of NF-\u03baB and MAPK signaling pathways","volume":"14","author":"Xiao","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0615","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ptr.8050","article-title":"Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights","volume":"38","author":"Sohel","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155623","article-title":"Detoxification and underlying mechanisms towards toxic alkaloids by Traditional Chinese Medicine processing: a comprehensive review","volume":"129","author":"Shan","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0625","first-page":"51","article-title":"Review on extraction technology of alkaloids from plants","volume":"22","author":"Shang","year":"2002","journal-title":"Mod. Chem Ind."},{"issue":"26","key":"10.1016\/j.ijbiomac.2025.148811_bb0630","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8315","article-title":"Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0635","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.3390\/cancers3022274","article-title":"Tetrandrine, a compound common in Chinese traditional medicine, preferentially kills breast cancer tumor initiating cells (TICs) in vitro","volume":"3","author":"Xu","year":"2011","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0640","article-title":"Anticancer activity of tetrandrine by inducing apoptosis in human breast cancer cell line MDA-MB-231 in vivo","volume":"2020","author":"Wang","year":"2020","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.148811_bb0645","doi-asserted-by":"crossref","first-page":"9086","DOI":"10.1158\/0008-5472.CAN-04-0313","article-title":"Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S\u2013specific cyclin-dependent kinases and by inducing p53 and p21Cip1","volume":"64","author":"Meng","year":"2004","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0650","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11418-013-0765-0","article-title":"Tetrandrine triggers apoptosis and cell cycle arrest in human renal cell carcinoma cells","volume":"68","author":"Chen","year":"2014","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114689","article-title":"Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog\/Gli1 signaling pathway","volume":"283","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0660","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.canlet.2008.03.009","article-title":"Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins","volume":"269","author":"Kunnumakkara","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0665","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jff.2014.12.014","article-title":"Demethoxycurcumin induces autophagic and apoptotic responses on breast cancer cells in photodynamic therapy","volume":"12","author":"Lin","year":"2015","journal-title":"J. Funct. Foods"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0670","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12645-025-00319-0","article-title":"Modulatory effects of bisdemethoxycurcumin-conjugated silver\/selenium nanoparticles on 7, 12-dimethylbenz (a) anthracene-induced mammary tumorigenesis","volume":"16","author":"Adefisan-Adeoye","year":"2025","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108413","article-title":"Anti-cancer potential of dehydrozingerone\u2019s phenoxy-acetamide derivatives: discovery of a potent lead with dual anti-proliferative and anti-metastatic activities","volume":"159","author":"Kumar","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0680","doi-asserted-by":"crossref","first-page":"246","DOI":"10.15537\/smj.2023.44.3.20220768","article-title":"Efficacy of resveratrol against breast cancer and hepatocellular carcinoma cell lines","volume":"44","author":"Alkharashi","year":"2023","journal-title":"Saudi Med. J."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0685","first-page":"66","article-title":"Resveratrol increases the sensitivity of breast cancer MDA-MB-231 cell line to cisplatin by regulating intrinsic apoptosis","volume":"24","author":"F","year":"2021","journal-title":"Iran. J. Basic Med. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148811_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141370","article-title":"Quercetin suppresses twist to induce apoptosis in MCF-7 breast cancer cells","volume":"10","author":"Ranganathan","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/srep24049","article-title":"Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis","volume":"6","author":"Srivastava","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0700","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1756-9966-29-167","article-title":"Catechin hydrate suppresses MCF-7 proliferation through TP53\/caspase-mediated apoptosis","volume":"29","author":"Alshatwi","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0705","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.10398","article-title":"Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol","volume":"198","author":"Hung","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0710","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v68.10974","article-title":"Inhibition of triple-negative breast cancer growth via delphinidin-mediated suppression of the JAK2\/STAT3\/PD-L1 pathway","volume":"68","author":"Yu","year":"2024","journal-title":"Food Nutr. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0715","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-16608-2","article-title":"Grape seed proanthocyanidin extract inhibits DNA and protein damage and labile iron, enzyme, and cancer cell activities","volume":"12","author":"Habib","year":"2022","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148811_bb0720","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1007\/s13277-014-2233-1","article-title":"Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0725","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2174\/1874467215666220616145216","article-title":"Resveratrol in cancer treatment with a focus on breast cancer","volume":"16","author":"Kowsari","year":"2023","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0730","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1593\/tlo.07100","article-title":"Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model","volume":"1","author":"Schlachterman","year":"2008","journal-title":"Transl. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0735","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.753","article-title":"CCN5 activation by free or encapsulated EGCG is required to render triple-negative breast cancer cell viability and tumor progression","volume":"9","author":"Das","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0740","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.pharep.2017.04.008","article-title":"Epigallocatechin-3-gallate promotes apoptosis in human breast cancer T47D cells through down-regulation of PI3K\/AKT and Telomerase","volume":"69","author":"Moradzadeh","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0745","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3390\/antiox9121208","article-title":"Green tea catechins induce inhibition of PTP1B phosphatase in breast cancer cells with potent anti-cancer properties: in vitro assay, molecular docking, and dynamics studies","volume":"9","author":"Kuban-Jankowska","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0750","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3153\/FH24008","article-title":"Green tea extracts and substantial catechin derivatives: evaluation of their potential against breast cancer","volume":"10","author":"\u00d6zenver","year":"2024","journal-title":"Food Health."},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.148811_bb0755","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ejca.2004.06.018","article-title":"Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2\/neu-transfected human breast cancer cells through tyrosine kinase suppression","volume":"40","author":"Way","year":"2004","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0760","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1385\/MO:22:2:129","article-title":"In vitro and in vivo antitumorigenic activity of a mixture of lysine, proline, ascorbic acid, and green tea extract on human breast cancer lines MDA-MB-231 and MCF-7","volume":"22","author":"Roomi","year":"2005","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0765","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/jpbs.jpbs_311_22","article-title":"Preparation and characterization of capsaicin encapsulated polymeric micelles and studies of synergism with nicotinic acids as potential anticancer nanomedicines","volume":"15","author":"Shamsheer","year":"2023","journal-title":"J. Pharm. Bioallied Sci."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0770","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1021\/acs.jmedchem.2c01594","article-title":"Anticancer activity of region B capsaicin analogs","volume":"66","author":"Brown","year":"2023","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0775","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/biom15040486","article-title":"Antitumor assessment of liposomal beta-carotene with tamoxifen against breast carcinoma cell line: an in vitro study","volume":"15","author":"Elsayed","year":"2025","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0780","first-page":"3842","article-title":"Luteolin inhibits cell cycle progression and induces apoptosis of breast cancer cells through downregulation of human telomerase reverse transcriptase","volume":"17","author":"Huang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0785","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/21691401.2024.2306529","article-title":"Studying the effects of secondary metabolites isolated from Cycas thouarsii R. Br. leaves on MDA-MB-231 breast cancer cells","volume":"52","author":"Alotaibi","year":"2024","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology."},{"issue":"03","key":"10.1016\/j.ijbiomac.2025.148811_bb0790","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cpt.2024.07.003","article-title":"Spices and culinary herbs for the prevention and treatment of breast cancer: a comprehensive review with mechanistic insights","volume":"3","author":"Ali","year":"2025","journal-title":"Cancer Pathogenesis and Therapy."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb0795","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3892\/ol.2020.12191","article-title":"Potent antitumor activity of cepharanthine against triple-negative breast cancer spheroids compared with tetrandrine","volume":"20","author":"Kiyomi","year":"2020","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0800","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0959-8049(01)00356-2","article-title":"The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7\/adr cells","volume":"38","author":"Fu","year":"2002","journal-title":"Eur. J. Cancer"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0805","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1248\/cpb.59.1476","article-title":"Fangchinoline inhibits breast adenocarcinoma proliferation by inducing apoptosis","volume":"59","author":"Xing","year":"2011","journal-title":"Chem. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148811_bb0810","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.5114\/aoms\/132969","article-title":"Berberine induces apoptosis and arrests the cell cycle in multiple cancer cell lines","volume":"19","author":"Li","year":"2021","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0815","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3390\/molecules25030506","article-title":"Berberine impairs the survival of triple negative breast cancer cells: cellular and molecular analyses","volume":"25","author":"El Khalki","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0820","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1871526517666170531113759","article-title":"Ethanolic extract of Berberis vulgaris fruits inhibits the proliferation of MCF-7 breast cancer cell line through induction of apoptosis","volume":"17","author":"Ghafourian","year":"2017","journal-title":"Infectious Disorders-Drug Targets"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb0825","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3390\/biomedicines13061355","article-title":"The potential of matrine in the treatment of breast cancer: a review","volume":"13","author":"Yang","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0830","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39655-9","article-title":"MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K\/AKT pathway","volume":"13","author":"Wei","year":"2023","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0835","first-page":"1796","article-title":"Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt\/\u03b2-catenin signaling pathway","volume":"9","author":"Xie","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152852","article-title":"Sophoraflavanone G from Sophora flavescens induces apoptosis in triple-negative breast cancer cells","volume":"61","author":"Huang","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0845","doi-asserted-by":"crossref","DOI":"10.1038\/srep03098","article-title":"The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy","volume":"3","author":"Liu","year":"2013","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148811_bb0850","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.3390\/cancers16122257","article-title":"The anticancer application of delivery systems for honokiol and magnolol","volume":"16","author":"Dominiak","year":"2024","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0855","first-page":"168","article-title":"Combined application of honokiol and 2-deoxyglucose against MCF7 breast cancer cells under hypoxia","volume":"56","author":"Scherbakov","year":"2023","journal-title":"Engineering Proceedings."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0860","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/horticulturae11040387","article-title":"Variations in the mineral composition of houpoea officinalis flowers at different stages of development","volume":"11","author":"Yang","year":"2025","journal-title":"Horticulturae"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0865","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/ijms24010366","article-title":"Inhibitory effects of ursolic acid on the stemness and progression of human breast cancer cells by modulating argonaute-2","volume":"24","author":"Liao","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113007","article-title":"Oleanolic acid combined with olaparib enhances radiosensitization in triple negative breast cancer and hypoxia imaging with 18F-FETNIM micro PET\/CT","volume":"150","author":"Xu","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148811_bb0875","first-page":"549","article-title":"Root extract of Prunella vulgaris inhibits in vitro and in vivo carcinogenesis in MCF-5 human breast carcinoma cells via suppression of angiogenesis, induction of apoptosis, cell cycle arrest and modulation of PI3K\/AKT signalling pathway","volume":"24","author":"Gao","year":"2019","journal-title":"JBUON"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0880","series-title":"Role of Microbes in Sustainable Development: Human Health and Diseases","first-page":"441","article-title":"Bacteria and bacteria-based products in cancer therapy: current status and future advances","author":"Jangra","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0885","series-title":"Current Strategies in Cancer Gene Therapy","first-page":"111","article-title":"Use of bacteria in cancer therapy","author":"Sarotra","year":"2017"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0890","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/biom14070831","article-title":"Bacteriocins in cancer treatment: mechanisms and clinical potentials","volume":"14","author":"Wang","year":"2024","journal-title":"Biomolecules"},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148811_bb0895","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.3390\/cancers14194758","article-title":"Bacteriocins as potential therapeutic approaches in the treatment of various cancers: a review of in vitro studies","volume":"14","author":"Molujin","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0900","series-title":"Entrepreneurship with Microorganisms","first-page":"89","article-title":"Fungal metabolites and their importance in pharmaceutical industry","author":"Das","year":"2024"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0905","article-title":"Inhibition of cell growth and induction of apoptosis by Antrodia camphorata in HER-2\/neu-overexpressing breast cancer cells through the induction of ROS, depletion of HER-2\/neu, and disruption of the PI3K\/Akt signaling pathway","volume":"2012","author":"Lee","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"05","key":"10.1016\/j.ijbiomac.2025.148811_bb0910","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1142\/S0192415X13500791","article-title":"Cytotoxic effect and induction of apoptosis in human cervical cancer cells by Antrodia camphorata","volume":"41","author":"Yang","year":"2013","journal-title":"Am. J. Chin. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0915","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3892\/mmr.2017.7207","article-title":"Ethanol extract of Antrodia camphorata inhibits proliferation of HCT-8 human colorectal cancer cells by arresting cell cycle progression and inducing apoptosis","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148811_bb0920","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s13659-024-00493-5","article-title":"Marine natural products as a source of novel anticancer drugs: an updated review (2019\u20132023)","volume":"15","author":"El-Seedi","year":"2025","journal-title":"Natural Products and Bioprospecting."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148811_bb0925","article-title":"Marine-derived bioactive proteins and peptides: A review of current knowledge on anticancer potentials, clinical trials, and future prospects","volume":"19","author":"Okeke","year":"2024","journal-title":"Nat. Prod. Commun."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0930","doi-asserted-by":"crossref","first-page":"100","DOI":"10.62347\/JGQA3746","article-title":"Exploring the seas for cancer cures: the promise of marine-derived bioactive peptide","volume":"15","author":"Rafieezadeh","year":"2024","journal-title":"Int J Biochem Mol Biol"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0935","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/md19070363","article-title":"Marine antitumor peptide dolastatin 10: biological activity, structural modification and synthetic chemistry","volume":"19","author":"Gao","year":"2021","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0940","series-title":"Marine Biomaterials: Therapeutic Potential","first-page":"351","article-title":"Marine origin bioactive peptides: novel advances in the therapeutic potential","author":"Dehghani","year":"2022"},{"issue":"53","key":"10.1016\/j.ijbiomac.2025.148811_bb0945","doi-asserted-by":"crossref","first-page":"31909","DOI":"10.1039\/D0RA05856D","article-title":"Retracted article: the synthesis and biological activity of marine alkaloid derivatives and analogues","volume":"10","author":"Zhou","year":"2020","journal-title":"RSC Adv."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148811_bb0950","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/md19070374","article-title":"Marine alkaloids: Compounds with in vivo activity and chemical synthesis","volume":"19","author":"Munekata","year":"2021","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148811_bb0955","doi-asserted-by":"crossref","first-page":"580","DOI":"10.34172\/apb.2021.068","article-title":"Breast cancer: a global concern, diagnostic and therapeutic perspectives, mechanistic targets in drug development","volume":"11","author":"Jan","year":"2020","journal-title":"Advanced Pharmaceutical Bulletin."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148811_bb0960","doi-asserted-by":"crossref","first-page":"9665","DOI":"10.3390\/molecules16119665","article-title":"A journey under the sea: the quest for marine anti-cancer alkaloids","volume":"16","author":"Tohme","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2022.03.007","article-title":"An overview of chemotoxicity and radiation toxicity in cancer therapy","volume":"155","author":"Yazbeck","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0970","series-title":"Management of Chemotherapeutic Agent Extravasation and Radiation Therapy Adverse Effects. Principles of Cancer Reconstructive Surgery","first-page":"237","author":"Fox","year":"2008"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148811_bb0975","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2174\/1570180820666230224112505","article-title":"Description and in silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the Lipinski\u2019s rule of 5","volume":"21","author":"Lohit","year":"2024","journal-title":"Letters in Drug Design & Discovery."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0980","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tifs.2021.02.006","article-title":"Recent advances to improve curcumin oral bioavailability","volume":"110","author":"Sabet","year":"2021","journal-title":"Trends Food Sci. Technol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148811_bb0985","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.14228","article-title":"Therapeutic potentials of genistein: New insights and perspectives","volume":"46","author":"Rasheed","year":"2022","journal-title":"J. Food Biochem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148811_bb0990","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2174\/0113895575297312240903055926","article-title":"Phytochemicals and nanotechnology: a powerful combination against breast cancer","volume":"25","author":"Shafi","year":"2025","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148811_bb0995","first-page":"6","article-title":"A review on phytochemical compounds used to treatment of breast cancer","author":"Banna","year":"2024","journal-title":"Glob Acad J Pharm Drug Res."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148811_bb1000","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1080\/10408398.2018.1537237","article-title":"The immunomodulatory potential of natural compounds in tumor-bearing mice and humans","volume":"59","author":"Pan","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"19","key":"10.1016\/j.ijbiomac.2025.148811_bb1005","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.3390\/nu14194075","article-title":"Immunoceuticals: harnessing their immunomodulatory potential to promote health and wellness","volume":"14","author":"Tieu","year":"2022","journal-title":"Nutrients"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025093687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025093687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:16:33Z","timestamp":1766081793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025093687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":201,"alternative-id":["S0141813025093687"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148811","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutraceuticals in breast cancer therapy: Mechanistic insights and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148811","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"148811"}}